Axel Hinke Selected Research

Radiotherapy

2/2015	Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.
8/2014	Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
10/2011	Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study.
10/2010	Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.
9/2008	Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
3/2008	Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.
10/2002	Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Axel Hinke Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 08/2005
17	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2007
14	Breast Neoplasms (Breast Cancer) 06/2020 - 12/2005
11	Multiple Myeloma 04/2023 - 06/2004
7	Adenocarcinoma 01/2024 - 08/2006
6	Rectal Neoplasms (Rectal Cancer) 03/2021 - 10/2002
6	Disease Progression 02/2016 - 09/2009
6	Infections 01/2016 - 10/2004
5	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 03/2004
4	Nausea 01/2018 - 01/2005
4	Vomiting 01/2018 - 01/2005
4	Lymphoma (Lymphomas) 01/2016 - 02/2011
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2003
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2011
3	Pathologic Complete Response 10/2020 - 06/2009
3	Stomatitis 01/2018 - 02/2011
3	Neutropenia 02/2015 - 10/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 08/2006
3	Thrombocytopenia (Thrombopenia) 05/2013 - 11/2002
2	Squamous Cell Carcinoma of Head and Neck 01/2024 - 10/2020
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2016 - 04/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2013 - 11/2002
2	Alopecia (Baldness) 04/2013 - 06/2003
2	Hand-Foot Syndrome 08/2010 - 10/2002
2	Body Weight (Weight, Body) 08/2007 - 06/2003
1	Kidney Neoplasms (Kidney Cancer) 12/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2023
1	Smoldering Multiple Myeloma 04/2023
1	Microsatellite Instability 01/2022
1	Thrombocytosis (Thrombocythemia) 09/2021
1	Hyperthermia 03/2021
1	Pain (Aches) 01/2020

Drug/Important Bio-Agent (IBA)

12	Capecitabine (Xeloda)FDA Link 02/2016 - 10/2002
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 08/2005
10	Trastuzumab (Herceptin)FDA Link 01/2022 - 08/2007
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 09/2007
8	Bevacizumab (Avastin)FDA Link 06/2021 - 08/2011
6	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 09/2007
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2005
5	AnthracyclinesIBA 01/2018 - 11/2002
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
4	Cetuximab (Erbitux)FDA Link 01/2022 - 03/2008
4	Leucovorin (Folinic Acid)FDA Link 10/2015 - 09/2007
4	Epirubicin (Ellence)FDA LinkGeneric 07/2013 - 06/2009
4	Melphalan (Alkeran)FDA LinkGeneric 09/2010 - 10/2004
3	NivolumabIBA 12/2023 - 06/2020
3	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 08/2006
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 04/2009
3	Thalidomide (Thalomid)FDA Link 01/2020 - 04/2009
3	Bendamustine Hydrochloride FDA Link 01/2016 - 04/2013
3	Rituximab (Mabthera)FDA Link 01/2016 - 11/2002
3	fludarabineIBA 01/2016 - 11/2002
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2015 - 10/2004
3	Prostate-Specific Antigen (Semenogelase)IBA 02/2015 - 06/2009
3	Gemcitabine FDA Link 10/2013 - 08/2006
3	Prednisolone (Predate)FDA LinkGeneric 09/2010 - 11/2005
2	avelumabIBA 01/2024 - 01/2022
2	RamucirumabIBA 01/2024 - 01/2022
2	Docetaxel (Taxotere)FDA Link 01/2022 - 10/2020
2	IpilimumabIBA 01/2022 - 06/2020
2	Circulating Tumor DNAIBA 01/2021 - 12/2020
2	Neurokinin-1 Receptor AntagonistsIBA 01/2018 - 05/2016
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 01/2017
2	Hormones (Hormone)IBA 01/2017 - 02/2015
2	human ERBB2 proteinIBA 01/2017 - 08/2007
2	Capsules (Microcapsules)IBA 08/2014 - 06/2009
2	Vincristine (Oncovin)FDA LinkGeneric 04/2013 - 11/2005
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2011 - 08/2011
2	taxaneIBA 08/2010 - 08/2007
2	Amifostine (Ethyol)FDA LinkGeneric 09/2009 - 06/2003
2	Carboplatin (JM8)FDA LinkGeneric 09/2007 - 08/2005
1	Cancer VaccinesIBA 01/2024
1	pembrolizumabIBA 01/2024
1	Tyrosine Kinase InhibitorsIBA 12/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	pazopanib FDA Link 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	tremelimumabIBA 10/2020
1	durvalumabIBA 10/2020
1	ixazomibIBA 01/2020
1	ametantrone (HAQ)IBA 01/2020
1	Guanosine Diphosphate (GDP)IBA 01/2020
1	Fibroblast Growth Factor 7 FDA Link 01/2018
1	Erythromycin (Erycette)FDA LinkGeneric 12/2017
1	Panitumumab (Vectibix)FDA Link 12/2017

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 01/2024 - 06/2004
26	Therapeutics 12/2023 - 11/2005
7	Radiotherapy 02/2015 - 10/2002
6	Adjuvant Chemotherapy 01/2017 - 06/2010
5	Combination Drug Therapy (Combination Chemotherapy) 10/2015 - 08/2005
5	Prostatectomy (Retropubic Prostatectomy) 02/2015 - 03/2004
3	Chemoradiotherapy 10/2010 - 06/2003
3	Stem Cell Transplantation 09/2010 - 06/2004
2	Immunotherapy 12/2023 - 06/2020
2	Radioimmunotherapy 01/2022 - 10/2020
2	Neoadjuvant Therapy 03/2021 - 11/2015
2	Adjuvant Radiotherapy 08/2013 - 06/2009
1	Hematopoietic Stem Cell Transplantation 01/2018